• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NEU

NEUREN PHARMACEUTICALS LIMITED

0.94% ! $20.39
Market Cap $2.573B  !
Healthcare Biotechnology
Add to My Watchlist

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NEU
Share Price
277 278 279
13:05 16K 8.3M
13:05 Last post  TomDi Comments Created with Sketch.  16K  Views Created with Sketch.  8.3M 
NEU
Ann: Neuren partners with Hope for HIE to support NNZ-2591 		06:11 6 3.3K
06:11 Last post  Piton72 Comments Created with Sketch.  6  Views Created with Sketch.  3.3K 
NEU
Ann: NNZ-2591 Angelman top-line results presentation 		09/09/25 6 4.4K
Metals & Mining SECTOR NEWS

LU7 and Macquarie apply for AEA Grant to transform solar recycling

Explore now right-arrow Created with Sketch.
LU7
10 Sep 2025
LITHIUM UNIVERSE LIMITED
09/09/25 Last post  Piton72 Comments Created with Sketch.  6  Views Created with Sketch.  4.4K 
NEU
NEU chart
38 39 40
09/09/25 2.3K 1.3M
09/09/25 Last post  ASXcharts Comments Created with Sketch.  2.3K  Views Created with Sketch.  1.3M 
NEU
M&A
3 4 5
09/09/25 253 141K
09/09/25 Last post  Piton72 Comments Created with Sketch.  253  Views Created with Sketch.  141K 
NEU
Ann: First site initiated for Neuren's PMS Phase 3 trial 		09/09/25 25 11K
09/09/25 Last post  Steed1 Comments Created with Sketch.  25  Views Created with Sketch.  11K 
NEU
Ann: Change of Director's Interest Notice 		09/09/25 24 6.9K
09/09/25 Last post  Edmorgrimm Comments Created with Sketch.  24  Views Created with Sketch.  6.9K 
NEU
Acadia
26 27 28
09/09/25 1.6K 852K
09/09/25 Last post  Piton72 Comments Created with Sketch.  1.6K  Views Created with Sketch.  852K 

See All Discussions arrow Created with Sketch.

Timeline

Neuren partners with Hope for HIE to support NNZ-2591
09 Sep 07:30
 
Change of Director's Interest Notice
08 Sep 19:08
 
Application for quotation of securities - NEU
28 Aug 16:43
 
Investor Presentation, 27 August 2025
27 Aug 11:21
 
H1 2025 profit after tax A$15m, up from A$8m in H1 2024
27 Aug 09:24
 
Half Yearly Report and Accounts
27 Aug 09:21
 
View More arrow Created with Sketch.

Featured News

NEWS Outstanding thick high-grade gold revealed in first Greenewood assays
right-arrow Created with Sketch.
NEWS New targets and high-grade intercepts drive Bullabulling drill expansion
right-arrow Created with Sketch.
MEM Memphasys secures transformational A$325K initial order with exclusive Middle East partnership
right-arrow Created with Sketch.
NEWS How to handle a financial crisis and turn setbacks into setups
right-arrow Created with Sketch.
AII Why Almonty Industries is THE tungsten mining stock to watch
right-arrow Created with Sketch.
NEWS The 4 sectors poised to benefit from Australia's immigration wave
right-arrow Created with Sketch.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$20.39 		Change
0.190(0.94%) 		Mkt cap ! $2.573B
Open High Low Value Volume
$20.19 $20.42 $19.86 $8.368M 415.7K

Buyers (Bids)

No. Vol. Price($)
19 1484 $20.38
 

Sellers (Offers)

Price($) Vol. No.
$20.39 1159 13
View Market Depth
Last trade - 13.46pm 10/09/2025 (20 minute delay) ?
Last
$20.37 		  Change
0.190 ( 0.76 %)
Open High Low Volume
$20.10 $20.41 $19.87 89809
Last updated 14.06pm 10/09/2025 ?
NEU (ASX) Chart

Top Stories

Haranga 'exceeds expectations' with broad, shallow, high-grade gold drill results

Haranga Resources has confirmed broad, shallow, and high-grade gold mineralisation across multiple drillholes at its Ibel South Gold Project.
ASX Market Open: More Wall Street records to drag Oz out of Week 37 doldrums | Sep 10 Australian shares are heading into the middle of Week 37 with an advance ahead, with ASX 200 futures now pointing to a modest +0.2% gain.
EV Resources snaps up Nevada antimony project; will raise $5.5M for it, Los Lirios EV Resources has come out of its halt with a bang, unveiling the acquisition of the Dollar Antimony Project in Nye County alongside a raise.
Listen: HotCopper Wire Podcast 023 – Glowing gold, shining silver, and... wheat collusion? In this HotCopper Wire episode, we look at surging gold and silver as well as Trump's appeals court clash, and a wheat futures conspiracy.
Iluka responds to mineral sands downturn by halting Cataby, SR2 production Iluka Resources has suspended Cataby and its SR2 synthetic rutile kiln at Capel as it looks to navigate subdued demand for mineral sand.

Featured News

NEWS Outstanding thick high-grade gold revealed in first Greenewood assays
right-arrow Created with Sketch.
NEWS New targets and high-grade intercepts drive Bullabulling drill expansion
right-arrow Created with Sketch.
BML Boab Metals secures path to full ownership of Sorby Hills Project
right-arrow Created with Sketch.
NEWS How to handle a financial crisis and turn setbacks into setups
right-arrow Created with Sketch.
MEM Memphasys secures transformational A$325K initial order with exclusive Middle East partnership
right-arrow Created with Sketch.
NEWS The 4 sectors poised to benefit from Australia's immigration wave
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.